BIVI BioVie Inc.
$1.44▲ +8.27%
Healthcare
Other
Volume 195.9K
Avg Volume (10D) 199.5K
Key Metrics & Fundamentals
Market Cap
$12.50M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.82 - 3.79
% vs 50 MA
-12.12%
% vs 200 MA
-4.94%
RSI-14
51.8
MACD Histogram
+0.0300
Beta (1Y vs SPY)
1.99
Free Cash Flow
-$4.12M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$5.64M
COGS
–
Operating Exp
$5.72M
Operating Income
-$5.72M
EBIT
-$5.72M
Pretax Income
-$5.65M
Net Income
-$5.65M
Price & Volume History
Loading chart…
Recent News
BioVie Invited to Present Data on Bezisterim in Long COVID at the NIH’s RECOVER-TLC Third Annual Workshop
GlobeNewswire · Oct 26, 2026 8:00 AM ET
MARKETS LIVE: Wall Street rebounds as Anthropic IPO filing revives AI trade
Proactive · Oct 26, 2026 6:48 AM ET
From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television
ACCESS Newswire · Oct 24, 2026 10:30 AM ET
BioVie reports positive Phase 2 Parkinson’s data for bezisterim
Proactive · Oct 20, 2026 9:53 AM ET
BioVie Presents Data on Bezisterim in Parkinson’s Disease at the 2026 American Neurological Association Annual Meeting
GlobeNewswire · Oct 20, 2026 8:00 AM ET
BioVie Presents Data on Bezisterim in Long COVID at the 2026 American Neurological Association Annual Meeting
GlobeNewswire · Oct 19, 2026 8:00 AM ET
MARKETS LIVE: Nasdaq leads Wall Street higher as tech shares recover
Proactive · Oct 19, 2026 6:59 AM ET
BioVie to present Long COVID and Parkinson’s trial results at American Neurological Association meeting
Proactive · Oct 14, 2026 9:50 AM ET
BioVie to Present New Bezisterim Findings in Parkinson’s Disease and Long COVID at the 2026 American Neurological Association Annual Meeting
GlobeNewswire · Oct 14, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BIVI's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.